OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 5.07 EUR -0.2% Market Closed
Market Cap: 113.3m EUR

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 16.83 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

Lowest
Price Target
12.63 EUR
149% Upside
Average
Price Target
16.83 EUR
232% Upside
Highest
Price Target
22.37 EUR
341% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
DBV
DBV Technologies SA
114% Upside
CUV
Clinuvel Pharmaceuticals Ltd
150% Upside
BRNS
Barinthus Biotherapeutics PLC
359% Upside
IKT
Inhibikase Therapeutics Inc
341% Upside
IMTX
Immatics NV
147% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
22% Upside
EXEL
Exelixis Inc
6% Downside
ACAD
ACADIA Pharmaceuticals Inc
31% Upside

Revenue
Forecast

Revenue Estimate
OSE Immunotherapeutics SA

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is -27%.

N/A
Past Growth
-27%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OSE Immunotherapeutics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

Net Income Estimate
OSE Immunotherapeutics SA

The compound annual growth rate of OSE Immunotherapeutics SA's net income for the next 3 years is -52%.

N/A
Past Growth
-52%
Estimated Growth
Estimates Accuracy
2%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
16.83 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 16.83 EUR with a low forecast of 12.63 EUR and a high forecast of 22.37 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
-27%

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is -27%.

What is OSE Immunotherapeutics SA's Net Income forecast?
Projected CAGR
-52%

The compound annual growth rate of OSE Immunotherapeutics SA's net income for the next 3 years is -52%.

Back to Top